Phase 2 Alzheimer Clinical Trials
87 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 87 trials
Recruiting
Phase 2Phase 3
ACP-204 in Adults With Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc.1,074 enrolled148 locationsNCT06159673
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Psychosis Associated With Alzheimer's Disease
Intra-Cellular Therapies, Inc.370 enrolled65 locationsNCT06540833
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc.320 enrolled70 locationsNCT06651567
Recruiting
Phase 2
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
Alzheimer Disease
University Hospital, Toulouse100 enrolled1 locationNCT07007208
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
ADEarly Alzheimer's Disease
Shanghai Auzone Biological Technology Co., Ltd.180 enrolled1 locationNCT07252440
Recruiting
Phase 2
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
Alzheimer DiseaseAlzheimer Disease Due to P. Gingivalis
Lighthouse Pharmaceuticals, Inc.300 enrolled39 locationsNCT06847321
Recruiting
Phase 2
Sleep Trial to Prevent Alzheimer's Disease
SleepAlzheimer Disease
University of Minnesota120 enrolled1 locationNCT04629547
Recruiting
Phase 2
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Alzheimer DiseaseMild Cognitive ImpairmentMemory Impairment
Johns Hopkins University52 enrolled1 locationNCT04601038
Recruiting
Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Alzheimer Disease
University of Minnesota201 enrolled1 locationNCT06274528
Recruiting
Phase 1Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Alzheimer s DiseaseBeta-AmyloidProdromal Alzheimer's Disease+2 more
AC Immune SA304 enrolled26 locationsNCT05462106
Recruiting
Phase 2
Alzheimer's Tau Platform: Master Protocol
Alzheimer DiseaseProdromal Alzheimer's DiseasePreclinical Alzheimer's Disease
Paul S. Aisen900 enrolled1 locationNCT06957418
Recruiting
Phase 1Phase 2
Low-Dose Radiotherapy for Alzheimer's Disease
DementiaAlzheimer DementiaAlzheimer Dementia (AD)+2 more
Evan Thomas50 enrolled1 locationNCT07693140
Recruiting
Phase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Merck Sharp & Dohme LLC340 enrolled79 locationsNCT07033494
Recruiting
Phase 2
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
Alzheimer Disease
Columbia University100 enrolled1 locationNCT04576793
Recruiting
Phase 1Phase 2
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Moderate Alzheimer Disease
NKGen Biotech, Inc.36 enrolled8 locationsNCT06189963
Recruiting
Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer s Disease
Novartis Pharmaceuticals407 enrolled74 locationsNCT07094516
Recruiting
Phase 1Phase 2
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Alzheimer DiseaseAlzheimer Disease, Early Onset
Arrowhead Pharmaceuticals112 enrolled3 locationsNCT07221344
Recruiting
Phase 1Phase 2
Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
Alzheimer Disease
University Hospital, Toulouse9 enrolled1 locationNCT07367815
Recruiting
Phase 1Phase 2
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Alzheimer s Disease
AbbVie210 enrolled11 locationsNCT07599670
Recruiting
Phase 2
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd114 enrolled8 locationsNCT07027072